Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Visceral Leishmaniasis
100%
Trypanosoma Cruzi (T. cruzi)
82%
Chagas Disease
66%
Drug Target
55%
Leishmania Donovani
34%
Protease Inhibitors
32%
Preclinical Candidate
30%
Protozoan Parasites
30%
Cyclin-dependent Kinase 12
24%
Naphthyridine
24%
Kinetoplastid
24%
Mouse Model
21%
Metabolic Stability
20%
Infectious Diseases
19%
In Vivo Efficacy
18%
Drug Discovery
18%
Amino
18%
Leishmania
17%
Proteasome Inhibition
15%
Structure-activity Relationship
15%
Medicinal Chemistry
15%
Antitrypanosomal Activity
15%
Antileishmanial Activity
15%
Accessible Treatment
15%
Diamino
14%
Active Pharmaceutical Ingredients
14%
Parasitic Infection
13%
Current Treatment
13%
Further Development
12%
Trypanosoma Brucei
12%
Molecular Targets
12%
Mode of Action
12%
Potential Treatments
12%
In Vivo Activity
12%
Compound 8
12%
Qi Site
12%
Publication Process
12%
Material Difference
12%
Preclinical Development
12%
Guided Synthesis
12%
Resin
12%
Pyridazinone
12%
Human African Trypanosomiasis
12%
Cyclin-dependent Kinase
12%
5-Amino-1,2,3-triazole
12%
Folate Metabolism
12%
1,6-naphthyridine
12%
Pyrazolo[3,4-d]pyrimidine
12%
1,4-diazepines
12%
Structure-based Design
12%
Pharmacology, Toxicology and Pharmaceutical Science
Visceral Leishmaniasis
92%
Parasite
66%
Trypanosoma Cruzi
64%
Chagas Disease
53%
Proteasome
39%
Cyclin Dependent Kinase
36%
Structure Activity Relationship
27%
Proteasome Inhibitor
25%
Naphthyridine Derivative
24%
Mouse Model
22%
Mode of Action
21%
Enzymes
20%
Diseases
18%
Leishmania donovani
18%
Divalent
18%
Pharmacokinetics
18%
Parasitosis
16%
Pharmaceutical Chemistry
15%
Infection
15%
Kinetoplastida
15%
Leishmania
13%
Binding Site
12%
Carboxamide
12%
Antitrypanosomal
12%
Piperazine Derivative
12%
Methionine Transfer RNA Ligase
12%
Amitrole
12%
Pyrimidine Derivative
12%
Chelating Agent
12%
Nagana
12%
Transition Element
12%
Cryo-Electron Microscopy
11%
Benznidazole
9%
Nifurtimox
9%
Neglected Disease
9%
Side Effect
9%
Drug Discovery
6%
Molecular Target
6%
Tolerability
6%
Piperazine
6%
Antitarget
6%
Zinc Ion
6%
Metal Ion
6%
Leishmania infantum
6%
High-Throughput Screening
6%
Immunology and Microbiology
Proteasome
56%
Trypanosoma Cruzi
52%
Visceral Leishmaniasis
38%
Parasite
37%
Kinetoplastida
27%
Leishmania donovani
25%
Chagas Disease
20%
Binding Site
16%
Structure Activity Relation
15%
Leishmania
14%
Protozoa
12%
Cytochrome
12%
Transfer RNA
12%
Proteomics
12%
Qi
12%
Folate Metabolism
12%
Codon
12%
Drug Binding Site
12%
Infectious Disease
10%
Cryo-Electron Microscopy
10%
Trypanosoma Brucei
9%
Amastigote
8%
Drug Resistance
8%
Infection
7%
Mouse Model
6%
Parasitic Disease
6%
Leishmania infantum
6%